PTEN and metastatic neoplasm: The PTEN locus at chromosome 10q24 is subject to frequent (~40%) genomic deletions in prostate cancers [106], with a significant association between PTEN deletion and an earlier onset of disease recurrence and a greater likelihood of metastatic disease.